You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

inosine

Showing 1 - 25 of 81
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor Trial in Beijing (Inosine 0.2g orally 3 times/day, PD-1/PD-L1 inhibitor ,chemo/targeting)

Completed
  • Advanced Solid Tumor
  • Inosine 0.2g orally 3 times/day
  • PD-1/PD-L1 inhibitor ,chemotherapy/targeting
  • Beijing, Beijing, China
    Qin li
Mar 30, 2023

Healthy Volunteers Trial in Basel (Inosine, Placebo)

Recruiting
  • Healthy Volunteers
  • Inosine
  • Placebo
  • Basel, BS, Switzerland
    University Hospital Basel, Department of Endocrinology
Mar 14, 2022

Stroke Trial in Saint Petersburg (Cytoflavin (Inosine + Nicotinamide + Riboflavin + Succinic Acid), Placebo)

Recruiting
  • Stroke
  • Cytoflavin (Inosine + Nicotinamide + Riboflavin + Succinic Acid)
  • Placebo
  • Saint Petersburg, Russian Federation
  • +2 more
Jul 7, 2023

Remaxol® Used in Treatment of Gallstone Disease Complicated With

Recruiting
  • Gallstone Disease
  • Obstructive Jaundice
  • Barnaul, Russian Federation
  • +8 more
Jun 28, 2023

Cytoflavin in Combination With Reperfusion in Stroke Patients

Not yet recruiting
  • Acute Stroke
  • Cytoflavin (succinic acid + inosine + nicotinamide + riboflavin)
  • Control
  • (no location specified)
Apr 4, 2022

Allergic Rhinitis, Asthma, Latent Tuberculosis Trial in Paddington (Poly ICLC, Poly I:C, R848)

Completed
Has Results
  • Allergic Rhinitis
  • +2 more
  • Poly ICLC
  • +5 more
  • Paddington, London, United Kingdom
    Imperial Clinical Respiratory Research Unit (ICRRU), St Mary's H
Nov 3, 2021

COVID-19 Trial in Yaroslavl (Molixan, Placebo)

Recruiting
  • COVID-19
  • Yaroslavl, Russian Federation
    Yaroslavl Regional Clinical Hospital for War Veterans - The Inte
Oct 8, 2021

Head Trauma,Closed Trial in Saint Petersburg, Saint-Petersburg (Cytoflavin ((Inosine + Nicotinamide + Riboflavin + Succinic

Recruiting
  • Head Trauma,Closed
  • Cytoflavin ((Inosine + Nicotinamide + Riboflavin + Succinic Acid)
  • Placebo
  • Saint Petersburg, Russian Federation
  • +2 more
Aug 17, 2021

Diabetic Neuropathies Trial in Russian Federation (Cytoflavin (Inosine + Nicotinamide + Riboflavin + Succinic Acid), Placebo)

Completed
  • Diabetic Neuropathies
  • Cytoflavin (Inosine + Nicotinamide + Riboflavin + Succinic Acid)
  • Placebo
  • Moscow, Russian Federation
  • +15 more
Jan 25, 2023

Amyotrophic Lateral Sclerosis Trial in Fort Lauderdale, Boston, Minneapolis (Inosine, Placebo)

Completed
Has Results
  • Amyotrophic Lateral Sclerosis
  • Inosine
  • Placebo
  • Fort Lauderdale, Florida
  • +2 more
Feb 1, 2021

Jaundice, Obstructive Trial in Russian Federation (Remaxol (succinate + methionine + inosine + nicotinamide), Ringer's Solution)

Completed
  • Jaundice, Obstructive
  • Remaxol (succinate + methionine + inosine + nicotinamide)
  • Ringer's Solution
  • Moscow, Russian Federation
  • +12 more
Jul 10, 2020

Multiple System Atrophy Trial in Seoul (1) Inosine 5'-monophosphate, Placebo)

Completed
  • Multiple System Atrophy
  • 1) Inosine 5'-monophosphate
  • Placebo
  • Seoul, Seou, Korea, Republic of
    Department of Neurology, Yonsei University College of Medicine
Jul 4, 2019

Jaundice; Malignant Trial in Russian Federation (Remaxol®, Ringer's Solution)

Completed
  • Jaundice; Malignant
  • Bryansk, Russian Federation
  • +17 more
Jul 9, 2020

Cognitive Dysfunction Trial in Russian Federation (Cytoflavin® solution, Cytoflavin® enteric-coated tablet, Placebo solution)

Completed
  • Cognitive Dysfunction
  • Cytoflavin® solution
  • +3 more
  • Chelyabinsk, Russian Federation
  • +12 more
Dec 9, 2019

Parkinson's Disease Trial in Puerto Rico, United States (Inosine, Placebo)

Completed
Has Results
  • Parkinson's Disease
  • Inosine
  • Placebo
  • Birmingham, Alabama
  • +61 more
Jul 8, 2020

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute

Active, not recruiting
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

Healthy Trial in Poznan (Cardio-pulmonary exercise test)

Completed
  • Healthy
  • Cardio-pulmonary exercise test
  • Poznań, Poland
    Poznan University of Physical Education
Nov 10, 2021

Specific Genotypes/Phenotypes of Pneumocystis Jirovecii in Solid

Not yet recruiting
  • Transplantation
  • Pulmonary Diseases
    • (no location specified)
    Jul 6, 2022

    Esophageal Squamous Cell Carcinoma, Intestinal Flora Trial in Suzhou (SintilimabCombined With Chemotherapy)

    Recruiting
    • Esophageal Squamous Cell Carcinoma
    • Intestinal Flora
    • SintilimabCombined With Chemotherapy
    • Suzhou, Jiangsu, China
      The first affiliated hospital of soochow university
    Jan 5, 2022

    Prostasomes as Diagnostic Tool for Prostate Cancer Detection

    Suspended
    • Prostate Cancer
    • Genetic analysis for the detection of prostasomes
    • Hackensack, New Jersey
      Hackensack University Medical Center
    Nov 28, 2022

    Advanced Hepatocellular Carcinoma Trial in Guangzhou (Bifidobacterium Bifidum Oral Product)

    Recruiting
    • Advanced Hepatocellular Carcinoma
    • Bifidobacterium Bifidum Oral Product
    • Guangzhou, Guangdong, China
      The Third Affiliated Hospital of Sun Yat-Sen University
    Nov 16, 2022

    Nephrotic Syndrome Steroid-Dependent Trial in Genova (Rituximab Biosimilar)

    Recruiting
    • Nephrotic Syndrome Steroid-Dependent
    • Rituximab Biosimilar
    • Genova, Italy
      IRCCS G. Gaslini
    Dec 19, 2022

    Multiyear Extensions of PD Trials

    Completed
    • Parkinson Disease
      • Rochester, New York
        CHeT Telemedicine (Site 363)
      Aug 1, 2022

      High Probability of Poorly Responding to Therapy With

      Completed
      • Renal Transplantation
      • MPA SNP
      • Vienna, Austria
        Department of Medicine III, Division of Nephrology
      Sep 9, 2020

      Ischemia: Xanthine, Hypoxanthine and Inosine Levels During

      Completed
      • Identify the Presence of a Marker of Ischemia/Hypoperfusion of the Brain Via Peripheral Blood
      • Ischemia/Hypoperfusion of Brain
        • Richmond, Virginia
          Virginia Commonwealth University
        Jul 27, 2018